BioHealth News Archive
Forget double helix. ‘Quadruple helix’ DNA discovered in human cells | ScienceBlog.com
In 1953, Cambridge researchers Watson and Crick published a paper describing the interweaving ‘double helix’ DNA structure – the chemical code for all life.…
Read More
ETC Announces AccelerateBaltimore™ Winning Companies
Baltimore City’s technology incubator, ETC (Emerging Technology Center), announced today that six companies have been selected to participate in the 2013 AccelerateBaltimore™ program –a…
Read More
Washington region raises an abysmal $95 million in Q4 venture funding – Washington Business Journal
Companies in Maryland, Virginia and D.C. raised a paltry $94.9 million in venture funding in the last three months of 2012, according to the…
Read More
Emergent BioSolutions, Inc., signs license agreement for flu vaccine production – Vaccine News Daily
Emergent BioSolutions, Inc., recently signed a license agreement for the manufacture and sale of VaxInnate Corporation’s recombinant influenza vaccine. The deal is considered to…
Read More
New Enterprise Associates tops list of most active VCs – Washington Business Journal
Bicoastal venture titan New Enterprise Associates ranked as the most active VC firm in the country last year, according to investment research firm CB…
Read More
Maryland budget reflects improving economy – baltimoresun.com
Gov. Martin O'Malley released a $37 billion spending plan Wednesday that for the first time in recent years contains no drastic cuts or proposed…
Read More
Blueprint Health’s new class shows there are still plenty of new ideas in the digital health pipeline – MedCity News
Another day, another class of digital health startups. That’s how it feels sometimes, with so many accelerators working with dozens of new companies each…
Read More
GSK seeks FDA approval for new GLP-1 agonist
British healthcare firm GlaxoSmithKline has filed for US regulatory approval of its new type 2 diabetes drug albiglutide, which belongs to the same group…
Read More
Peter Greenleaf steps down as MedImmune president, Bahija Jallal chosen as replacement – Capital Business Blog – The Washington Post
Peter Greenleaf is stepping down down as president of Gaithersburg-based biotechnology giant MedImmune, according to a company spokesman, to take the helm of parent…
Read More
Bahija Jallal to replace Peter Greenleaf as head of MedImmune – Baltimore Business Journal
MedImmune executive Bahija Jallal will be the new chief of the Gaithersburg biotech under a leadership shuffle by parent company AstraZeneca, a spokesman confirmed…
Read More
Medical device is “sector darling” when it comes to healthcare VC deals in fourth quarter – MedCity News
There might be a lot of griping about how tight the venture capital world is when it comes to funding medical devices, but reality…
Read More
At J.P. Morgan Conference, VCs Upbeat on Medical Devices – Venture Capital Dispatch – WSJ
The buzz around biotechnology investing that could be felt this year at the J.P. Morgan Healthcare Conference could reach the beleaguered medical-device sector as…
Read More
Backed By New Partnerships With Humana, Aetna & Verizon, Blueprint Health Debuts Its Third Class Of Healthcare Disruptors – TechCrunch
If I’ve said it once, I’ve said it one bajillion times. If you’re going to start a business accelerator, don’t clone Y Combinator or…
Read More
Deals Of The Week Catches Up with SR One – The IN VIVO Blog
Amid the exhaustive meet-and-greet opportunities available at the 2013 JP Morgan conference, which took place in San Francisco earlier this week, we met with…
Read More
Baltimore ranks No. 4 among America’s hottest tech cities – Baltimore Business Journal
The Baltimore-area ranks fourth on a new Forbes list of the hottest tech markets in the country. The report, conducted by Praxis Strategy Group,…
Read More